Salidroside improved gouty arthritis by reprogramming COX-2 and 5-LOX-mediated arachidonic acid metabolism and by influencing NF-κB signaling to polarize macrophages away from the M1 phenotype33. This evidence concerns the gene NFKB1 and gout.